MedPath

SMS Maama Project COVID-19

Not Applicable
Completed
Conditions
Birth Injuries
Pregnancy Complications
Interventions
Behavioral: mHealth Platform
Registration Number
NCT04739462
Lead Sponsor
University of Minnesota
Brief Summary

The study's purpose is to demonstrate the ability of an mHealth platform as a feasible way of sharing information in a time of restricted movement in order to inform future studies.

Detailed Description

The primary objective of this trial is to assess whether an mHealth platform increases maternal health knowledge in the areas of birth preparedness, pregnancy, and birth complications as measured by the pre- and post-surveys in comparison to routine antenatal care.

The secondary objectives of this trial are;

1. To provide knowledge of COVID-19 symptoms, transmission, diagnosis, and treatment, in a time of social distancing and learning.

2. To improve access and linkages to maternal health services and information as well as provide appropriate referrals for pregnant females.

3. Inform the adoption of mHealth into future health delivery plans.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
248
Inclusion Criteria
  • Own a personal mobile phone
  • Attend ANC at Kisenyi Health Centre IV, Kawempe Hospital or Rubaga Hospital
  • Are at least 24-26 weeks estimated gestational age
  • Literate in English or Luganda
  • Capable of sending/receiving text messages
Read More
Exclusion Criteria
  • Females who plan to travel out of Uganda during the study period
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
InterventionmHealth PlatformParticipants in this arm will receive the study intervention.
Primary Outcome Measures
NameTimeMethod
Change in Pre- to Post-Intervention Knowledgeup to 18 weeks

Outcome is reported as the percent of pregnant participants who recognize key danger signs during pregnancy, labor and childbirth, and postpartum period. Knowledge is measured pre-intervention (approximately 24-26 weeks gestation) and post-intervention (approximately 2 weeks following delivery). The timeframe is calculated to be 16-18 weeks.

Secondary Outcome Measures
NameTimeMethod
Change in Knowledge on COVID-19up to 18 weeks

Outcome reported as the percent of pregnant participants who identify key symptoms, modes of transmission, and measures to prevent SARS-CoV-2 infection (COVID-19). Knowledge is measured pre-intervention (approximately 24-26 weeks gestation) and post-intervention (approximately 2 weeks following delivery). The timeframe is calculated to be 16-18 weeks.

Change in Breastfeeding Knowledgeup to 18 weeks

Outcome is reported as the percent of pregnant participants who believe it is safe to breastfeed their newborn if they have or have had COVID-19. Knowledge is measured pre-intervention (approximately 24-26 weeks gestation) and post-intervention (approximately 2 weeks following delivery). The timeframe is calculated to be 16-18 weeks.

Antenatal Care Rateup to 18 weeks

Outcome is reported as the percent of pregnant participants who attend at least 4 antenatal care visits.

Change in Pregnancy Risk Knowledgeup to 18 weeks

Outcome is reported as the percent of pregnant participants who believe pregnant females are at increased risk for COVID-19. Knowledge is measured pre-intervention (approximately 24-26 weeks gestation) and post-intervention (approximately 2 weeks following delivery). The timeframe is calculated to be 16-18 weeks.

Skilled Birth Attendance Rateup to 18 weeks

Outcome is reported as the percent of pregnant participants who give birth at a hospital.

Rate of Negative Pregnancy Outcomesup to 18 weeks

Outcome is reported as the percent of pregnant participants who experience a negative pregnancy outcome (e.g. maternal/neonatal complications, miscarriage, stillbirth, and/or neonatal death).

Rate of COVID Testingup to 18 weeks

Outcome is reported as the percent of pregnant participants who were tested for SARS-CoV-2 during pregnancy.

Trial Locations

Locations (2)

University of Minnesota

🇺🇸

Minneapolis, Minnesota, United States

Makerere University

🇺🇬

Kampala, Uganda

© Copyright 2025. All Rights Reserved by MedPath